Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM25351
 | 1 | 67 | 0 | 0 | 0 | 0 | 0 | 0 | - C-C chemokine receptor type 1
- Gag-Pol polyprotein
- Human immunodeficiency virus type 1 integrase
- Human immunodeficiency virus type 1 reverse transcriptase
- Integrase
- Potassium voltage-gated channel subfamily H member 2
- Reverse transcriptase
- Sodium channel protein type 5 subunit alpha
- Uridine-5'-diphosphoglucuronosyltransferase 1A1
- Voltage-gated L-type calcium channel
- Voltage-gated potassium channel beta subunit Mink/subunit Kv7.1
- Voltage-gated potassium channel subunit Kv4.3
| - N-[2-(4-{[(4-fluorophenyl)methyl]carbamoyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
- Raltegravir
|
BDBM50001450
 | 29 | 25 | 0 | 14 | 0 | 0 | 0 | 0 | - Adenosine receptor
- BHE
- Mas-related G protein-coupled receptor X2 (MRGPRX2)
- Neurokinin 1 receptor
- Neurokinin 2 receptor
- Neurokinin 3 receptor
- Neuromedin-K receptor
- Prothrombin
- Substance K
- Substance P
- TACR2
- TACR3
| - (SP)Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
- Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met NH2
- Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
- Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2(Substance P)
- Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2.(Substance P)
- Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-amine
- ArgProLysProGlnGlnPhePheGlyLeuMet
- CHEMBL235363
- H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-D-Phe-Gly-Leu-Met-NH2
- H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2(Substance P)
- Substance P
- Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-MetNH2)
- Substance P analogue
- tachykinin substance P (SP)
|
BDBM50005463
 | 26 | 41 | 1 | 0 | 0 | 0 | 0 | 0 | - Bile salt export pump
- CCKBR
- Cholecystokinin
- Cholecystokinin A receptor
- Cholecystokinin B
- Cholecystokinin receptor
- GABA A Benzodiazepine
- Opioid receptor
| - (R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O
- (S)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
- (S)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide
- (Z)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide
- 1H-Indole-2-carboxylic acid ((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (L-364,718 ((S)-devazepide)
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (MK-329, L-364,718)
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(Devazepide or (R) L364718)
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(L-364718)
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(devazepide)
- 1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O. 0.15CH2Cl2
- CCK antagonist synthetic 17
- CCK antagonist synthetic 18
- CHEMBL9506
- DEVAZEPIDE
- L-364,718
- L-364718
- MK-329
|
BDBM50027065
 | 65 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-HT5
- 5-HT5B
- 5-hydroxytryptamine receptor 1A
- 5-hydroxytryptamine receptor 1B
- 5-hydroxytryptamine receptor 1D
- 5-hydroxytryptamine receptor 2A
- 5-hydroxytryptamine receptor 2B
- 5-hydroxytryptamine receptor 2C
- 5-hydroxytryptamine receptor 5A
- 5-hydroxytryptamine receptor 7 (5HT7)
- Adenylate cyclase
- Alpha-1A adrenergic receptor
- Beta-2 adrenergic receptor
- Cholecystokinin receptor
- D(2) dopamine receptor
- DRD1
- HTR1D
- HTR1E
- HTR1F
- HTR5A
- HTR6
- HTR7
- P-glycoprotein 1
- P-glycoprotein 1 and 3 (MDR1a/MDR1b)
- Serotonin (5-HT) receptor
- Serotonin 1B/1D receptor
- Serotonin receptor 2a and 2c (5HT2A and 5HT2C)
- adrenergic Alpha2
| - (5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
- (5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman
- 12'-hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione
- ERGOTAMINE
- Ergotamin
|
BDBM50067678
 | 18 | 25 | 1 | 24 | 0 | 0 | 0 | 0 | - 17-beta-Hydroxysteroid Dehydrogenase 5 (17-beta-HSD5, AKR1C3)
- Aldo-keto reductase family 1 member C1
- Aldo-keto reductase family 1 member C2
- Aldo-keto-reductase family 1 member C3
- Androgen Receptor
- Androgen receptor
- Bile salt export pump
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Glucocorticoid receptor
- Mineralocorticoid receptor
- Multidrug resistance-associated protein 4
- Progesterone receptor
- Testis-specific androgen-binding protein
| - (6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
- (6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate
- 17-Acetoxy-6alpha-methylprogesterone
- 17alpha-Hydroxy-6alpha-methylprogesterone acetate
- 6-alpha-Methyl-17-alpha-acetoxyprogesterone
- 6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
- 6alpha-Methyl-17-acetoxy progesterone
- 6alpha-Methyl-17alpha-hydroxyprogesterone acetate
- 6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
- MEDROXYPROGESTERONE
- Medroxyacetate progesterone
- Medroxyprogesterone 17-acetate
- Methylacetoxyprogesterone
- Metigestrona
- US9271961, MPA
- medroxyprogesterone acetate
|
BDBM50110183
 | 11 | 57 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- CDK2/CycE
- CDK4/CDK1
- CDK4/Cyclin D3
- CDK6/CycD3
- CDK6/cyclin D1
- CDK7/Cyclin H/MNAT1
- CaM kinase I alpha
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 5 (CDK5)
- Cyclin-Dependent Kinase 9 (CDK9)
- Cyclin-K
- Cyclin-dependent kinase 1
- Cyclin-dependent kinase 1/ G1/S-specific cyclin-D3
- Cyclin-dependent kinase 2
- Cyclin-dependent kinase 4
- Cyclin-dependent kinase 4/G1/S-specific cyclin-E1
- Cyclin-dependent kinase 6
- Cyclin-dependent kinase 7
- Cyclin-dependent kinase 9
- Cyclin-dependent-like kinase 5
- Dual-specificity tyrosine-phosphorylation regulated kinase 1A
- Homeodomain-interacting protein kinase 1
- Protein cereblon/Cyclin-dependent kinase 2
- Replicase polyprotein 1ab
- Serine/threonine-protein kinase pim-1
| - ABEMACICLIB
- Abemaciclib
- LY-2835219
- US10662186, Compound LY2835219
- US10696678, Example LY2835219
|
BDBM50205990
 | 22 | 6 | 2 | 38 | 0 | 0 | 0 | 0 | - Bile salt export pump
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Multidrug resistance-associated protein 4
- Oxytocin receptor
- Vasopressin V1a receptor
- Vasopressin V1b receptor
- Vasopressin V2 Receptor
- Vasopressin V2 receptor
- Vasopressin receptor
| |